These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14651971)

  • 1. Reduction of Sulindac to its active metabolite, sulindac sulfide: assay and role of the methionine sulfoxide reductase system.
    Etienne F; Resnick L; Sagher D; Brot N; Weissbach H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1005-10. PubMed ID: 14651971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes.
    Hamman MA; Haehner-Daniels BD; Wrighton SA; Rettie AE; Hall SD
    Biochem Pharmacol; 2000 Jul; 60(1):7-17. PubMed ID: 10807940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut Microbiota.
    Hirosawa K; Fukami T; Nagaoka M; Nakano M; Nakajima M
    Drug Metab Dispos; 2021 May; 50(5):725-733. PubMed ID: 35279645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the metabolism and biological activity of the epimers of sulindac.
    Brunell D; Sagher D; Kesaraju S; Brot N; Weissbach H
    Drug Metab Dispos; 2011 Jun; 39(6):1014-21. PubMed ID: 21383205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial uncoupling by the sulindac metabolite, sulindac sulfide.
    Leite S; Martins NM; Dorta DJ; Curti C; Uyemura SA; dos Santos AC
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):294-9. PubMed ID: 17040214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New membrane-associated and soluble peptide methionine sulfoxide reductases in Escherichia coli.
    Spector D; Etienne F; Brot N; Weissbach H
    Biochem Biophys Res Commun; 2003 Mar; 302(2):284-9. PubMed ID: 12604343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
    Kitamura S; Tatsumi K
    Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methionine sulfoxide reductase in Escherichia coli that reduces the R enantiomer of methionine sulfoxide.
    Etienne F; Spector D; Brot N; Weissbach H
    Biochem Biophys Res Commun; 2003 Jan; 300(2):378-82. PubMed ID: 12504094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism in vitro of sulindac. Sulfoxide-reducing enzyme systems in guinea pig liver.
    Kitamura S; Tatsumi K; Yoshimura H
    J Pharmacobiodyn; 1980 Jun; 3(6):290-8. PubMed ID: 6775073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine sulfoxide reductases: history and cellular role in protecting against oxidative damage.
    Weissbach H; Resnick L; Brot N
    Biochim Biophys Acta; 2005 Jan; 1703(2):203-12. PubMed ID: 15680228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dimethyl sulfoxide on sulindac disposition in rats.
    Swanson BN; Mojaverian P; Boppana VK; Dudash MR
    Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acidic non-steroidal anti-inflammatory drugs on human cytochrome P450 4A11 activity: Roles of carboxylic acid and a sulfur atom in potent inhibition by sulindac sulfide.
    Itoh H; Yamashita N; Kamijo S; Masuda K; Kato H; Yamaori S
    Chem Biol Interact; 2023 Sep; 382():110644. PubMed ID: 37499995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium and the methionine sulfoxide reductase system.
    Oien DB; Moskovitz J
    Molecules; 2009 Jul; 14(7):2337-44. PubMed ID: 19633607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free methionine-(R)-sulfoxide reductase from Escherichia coli reveals a new GAF domain function.
    Lin Z; Johnson LC; Weissbach H; Brot N; Lively MO; Lowther WT
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9597-602. PubMed ID: 17535911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure and backbone dynamics of the reduced form and an oxidized form of E. coli methionine sulfoxide reductase A (MsrA): structural insight of the MsrA catalytic cycle.
    Coudevylle N; Antoine M; Bouguet-Bonnet S; Mutzenhardt P; Boschi-Muller S; Branlant G; Cung MT
    J Mol Biol; 2007 Feb; 366(1):193-206. PubMed ID: 17157315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol.
    Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
    Drug Metab Dispos; 1981; 9(4):307-10. PubMed ID: 6114827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins.
    Moskovitz J; Weissbach H; Brot N
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2095-9. PubMed ID: 8700890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
    Swanson BN; Mojaverian P; Boppana VK
    J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal metabolism of sulindac: functional implications.
    Miller MJ; Bednar MM; McGiff JC
    J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.